Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Author is Bhatia, Shailender  [Clear All Filters]
B
Bhatia, S, Thompson JA.  2012.  Systemic therapy for metastatic melanoma in 2012: dawn of a new era.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(3):403-12. Abstract
Bhatia, S, Tykodi SS, Thompson JA.  2009.  Treatment of metastatic melanoma: an overview.. Oncology (Williston Park, N.Y.). 23(6):488-96. Abstract
Bhatia, S, Afanasiev O, Nghiem P.  2011.  Immunobiology of merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.. Current oncology reports. 13(6):488-97. Abstract
Bhatia, S, Moon J, Margolin KA, Weber JS, Lao CD, Othus M, Aparicio AM, Ribas A, Sondak VK.  2012.  Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.. PloS one. 7(11):e48787. Abstract
Brahmer, JR, Tykodi SS, Chow LQM, Hwu W-J, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K et al..  2012.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.. The New England journal of medicine. 366(26):2455-65. Abstract
C
Chapuis, AG, Thompson JA, Margolin KA, Rodmyre R, Lai IP, Dowdy K, Farrar EA, Bhatia S, Sabath DE, Cao J et al..  2012.  Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype.. Proceedings of the National Academy of Sciences of the United States of America. 109(12):4592-7. Abstract
M
Miller, NJ, Bhatia S, Parvathaneni U, Iyer JG, Nghiem P.  2013.  Emerging and Mechanism-Based Therapies for Recurrent or Metastatic Merkel Cell Carcinoma.. Current treatment options in oncology. Abstract
P
Paulson, KG, Iyer JG, Blom A, Warton ME, Sokil M, Yelistratova L, Schuman L, Nagase K, Bhatia S, Asgari MM et al..  2012.  Systemic Immune Suppression Predicts Diminished Merkel Cell Carcinoma-Specific Survival Independent of Stage.. The Journal of investigative dermatology. Abstract